Fundraising Fox

Mytos

YC S18

London, GB · 26 employees · 4 known investors

mytos.bio ↗

Mytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.

Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsIoTAutomationBiotechnologyin /mytosbio/@mytosbio

Founders & leadership· Y Combinator alumni (S18)

Ali Afshar
Ali Afsharin𝕏Founder/CEO
Ignacio Willats
Ignacio WillatsinFounder
Nn
Not named (CEO | Co-Founder)CEO | Co-Founder
Nn
Not named (Co-Founder)Co-Founder

Investors · 4

Y Combinator✓ verifiedMountain View · $500K – $500K
Artis VenturesSan Francisco
WingPalo Alto
Buckley VenturesreportedSan Francisco

In the news